John Edward Lundy, MD | |
220 East Hemlock, Deming, NM 88030 | |
(505) 546-2705 | |
(505) 546-2706 |
Full Name | John Edward Lundy |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 220 East Hemlock, Deming, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982795035 | NPI | - | NPPES |
26419 | Medicaid | NM | |
10001972 | Other | NM | LOVELACE |
19817 | Other | NM | PRESBYTERIAN |
0389 | Other | NM | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 83246NM (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
John Edward Lundy, MD 220 East Hemlock, Deming, NM 88030 Ph: (505) 546-2705 | John Edward Lundy, MD 220 East Hemlock, Deming, NM 88030 Ph: (505) 546-2705 |
News Archive
One of the major challenges in stem cell transplants is how to obtain sufficient numbers of these remarkably rare cells to put into patients. To help overcome this issue, research from the Centenary Institute, Royal Prince Alfred Hospital and the University of Sydney has found a way to increase the number of blood-forming stem cells when growing them outside of the body.
The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia at Augusta University has been selected as a designated laboratory for the National Cancer Institute's Molecular Analysis for Therapy Choice, or MATCH trial, which is assessing the effectiveness of targeting cancer-causing gene changes rather than cancer type.
A new study to examine facial preference, has found that people are attracted to facial characteristics indicative of personality traits similar to their own.
Arterial Remodeling Technologies disclosed today new data related to its bioresorbable stent platform—additional data that further validates the Company's innovative approach to simultaneously balance biocompatibility, biomechanics and bioresorption within a bioresorbable PLA (polylactic acid) stent.
Techniques developed by astronomers seeking a clear view of objects in space are coming closer to home, as eye care professionals apply the concept of wavefront optics to understanding-and correcting-subtle visual abnormalities of the human eye, according to a special article in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry.
› Verified 4 days ago